作者: Naresh Susarla , I.A. Karimi
DOI: 10.1016/J.COMPCHEMENG.2012.03.002
关键词:
摘要: … cliffs, mounting R&D costs, shrinking product pipelines, and stringent regulatory protocols are bringing a paradigm shift in the way pharmaceutical enterprises operate. Companies are …